Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- RA0358 - Provider product page

- Provider
- Oursmab
- Product name
- Nadunolimab (Biosimilar Reference Antibody) (IL1RAP)
- Antibody type
- Monoclonal
- Description
- Nadunolimab (also known as CAN04) is a fully human IgG1-kappa monoclonal antibody that targets the interleukin-1 receptor accessory protein (IL1RAP), a co-receptor essential for signaling of multiple pro-inflammatory cytokines in the IL-1 family (including IL-1¦Á, IL-1¦Â, IL-33, and IL-36). As an IgG1 isotype, it is designed to engage immune effector functions such as antibody-dependent cellular cytotoxicity (ADCC). By binding to IL1RAP, nadunolimab blocks cytokine-mediated signaling and may also deplete IL1RAP-expressing cells in the tumor microenvironment. It is being developed as a potential therapeutic for advanced solid tumors, with a focus on non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma, often in combination with chemotherapy.
- Reactivity
- Human
- Isotype
- IgG
- Vial size
- 100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
- Concentration
- Bottled at the concentration indicated on the vial.
- Storage
- Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
No comments: Submit comment
Supportive validation
- Submitted by
- Oursmab (provider)
- Main image

- Experimental details
- Nadunolimab (Biosimilar Reference Antibody) (IL1RAP)-RA0358-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.
Supportive validation
- Submitted by
- Oursmab (provider)
- Main image

- Experimental details
- ELISA plate pre-coated Antigen protein, can bind Nadunolimab (Biosimilar Reference Antibody) (IL1RAP)-RA0358 in a linear range of 15.63¨C125 ng/mL.